About Cell Marque
Founded in 1989 and now part of MilliporeSigma, Cell Marque specialises in immunohistochemistry (IHC) reagents and tissue diagnostic technologies for clinical pathology and translational research. The company develops and manufactures antibodies, detection systems and ancillary reagents that enable accurate characterisation of tissue biomarkers in formalin-fixed, paraffin-embedded samples. Its expertise in antibody development and assay performance supports laboratories conducting cancer diagnostics, biomarker evaluation and disease classification across a broad range of pathology disciplines. Cell Marque products are widely used in anatomical pathology workflows to support the identification and localisation of proteins within tissue specimens.
Cell Marque’s portfolio includes an extensive range of primary IHC antibodies covering numerous diagnostic and research biomarkers, together with detection systems such as the HiDef® Detection platform and a variety of ancillary reagents designed for tissue staining workflows. The company also offers specialty antibody collections tailored to disease-specific and organ-specific applications, supporting pathology investigations in oncology, haematopathology, gastrointestinal pathology, breast pathology, lung pathology and other clinical fields. These products support biomarker discovery, assay standardisation and routine tissue-based analysis in research and diagnostic laboratories.
Europa Biosite’s subsidiaries distribute for Cell Marque in Belgium, Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Luxembourg, Netherlands, Norway and Sweden.